If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 20.50
Bid: 20.00
Ask: 21.00
Change: 0.00 (0.00%)
Spread: 1.00 (5.00%)
Open: 20.50
High: 20.50
Low: 20.50
Prev. Close: 20.50
IOF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Production Update

18 Sep 2014 07:00

RNS Number : 9740R
Iofina PLC
18 September 2014
 

 

September 18, 2014

Iofina plc

("Iofina" or the "Company")

(LSE AIM: IOF)

 

August Production Update

 

 

 

Iofina, specialists in the exploration and production of iodine and iodine specialty chemical derivatives, today updates the market on its production during the month of August and its year end production forecast at its IOsorb® plants.

 

During the month of August, the Company reports that it produced 23.6MT of crystallized iodine compared with 24.5MT in July. A combination of factors including continued fracking, unanticipated design changes at IO#5 and IO#6, and a Salt Water Disposal (SWD) site upgrade by an operator that took longer to complete than forecast resulting in plant downtime, contributed to a decrease in production. These factors had a short-term negative effect on production, with production beginning to normalize in this last week. 

 

All six of the Company's IOsorb® plants are now in operation and producing crystallized iodine, and are expected to produce circa 25-30MT in September with increased exit rates moving forward.

 

The Company has also reviewed its production forecasts for 2014. In light of current fracking schedules, delays in the start of production at IO#5 and IO#6, and lower water volumes after the SWD site upgrade, Iofina anticipates that its overall 2014 crystallized iodine production will be circa 325-350MT of crystallized iodine. This represents close to a 2-fold year over year production increase but is below current market forecasts and managements targets.

 

While the iodine markets continue to remain challenging, Iofina has seen strong demand for its iodide derivatives, due to complete vertical integration and a strong product offering, resulting in the Company's revenues through to September anticipated to surpass the total sales for all of 2013. 

 

Commenting on today's update, President and CEO Dr. Tom Becker stated: "Whilst iodine production year to date has been below our expectations, we are encouraged that iodine production moving forward will show a favourable trend as these new short term items are rectified. We are focused on increasing the output of our current IOsorb® plants which will reduce our cost per kilo."

 

 

For further information, please contact:

Dr. Tom Becker, President and CEO

Iofina

Tel: +44 (0)20 3006 3135

 

John Prior/Rupert Krefting/Paul Gillam

Numis Securities

Tel: +44 (0)20 7260 1000

 

Rob Collins/Emily Morris/Liz Williamson

GMP Securities

Tel: +44(0)20 7647 2800

 

Media Contact:

Dominic Barretto/Anna Legge

Yellow Jersey PR

Tel: +44 (0)7768 537 739

 

 

 

About Iofina:

Iofina specializes in the exploration and production of iodine, iodine specialty chemical derivatives and produced water. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America based on Iofina's WET® IOsorb® technology. Iofina has production operations in the United States, specifically in Texas, Montana, Kentucky and Oklahoma. It has complete vertical integration from the production of iodine in the field to the manufacture of the chemical end-products derived from iodine to the consumer and the recycling of iodine using iodinated side-streams from waste chemical processes in Europe, North America and Asia. Iofina utilizes its portfolio of patented and patent pending technology, proprietary methods and trademarks throughout all business lines.

www.iofina.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKMGMLLNDGDZM
Date   Source Headline
2nd May 20247:00 amRNSFinal Results
16th Apr 20247:00 amRNSQ1 2024 Corporate Update
17th Jan 20247:00 amRNSHolding(s) in Company
15th Jan 20247:00 amRNSQ4 2023 Corporate Update
30th Nov 20237:00 amRNSIO#9 Update
20th Oct 20237:00 amRNSSigned Agreement for IO#10 and Q3 2023 Update
11th Sep 20237:00 amRNSInterim Results
25th Aug 20235:00 pmRNSHolding(s) in Company
24th Jul 20235:00 pmRNSHolding(s) in Company
20th Jul 20237:00 amRNSH1 Update and Updated Loan Facilities
14th Jun 20232:00 pmRNSResult of AGM
14th Jun 20237:00 amRNSIO#9 Iodine Plant Operating
9th May 20237:00 amRNSNotice of AGM
4th May 20237:00 amRNSInvestor Presentation
28th Apr 20234:45 pmRNSHolding(s) in Company
28th Apr 20237:00 amRNSGrant of Share Options
25th Apr 20237:00 amRNS2022 FULL YEAR RESULTS
12th Apr 20237:00 amRNSProduction Update
20th Feb 20237:00 amRNSDirector/PDMR Shareholding
6th Feb 20237:00 amRNSTrading Update
9th Jan 20237:00 amRNSMarket Update
28th Dec 20222:34 pmRNSHolding(s) in Company
14th Dec 20227:00 amRNSIofina Chemical Awarded ISO Certification
21st Nov 20227:00 amRNSChange of Adviser
28th Oct 20227:00 amRNSFinalised Terms for IO9 & Q3 Production Update
26th Sep 202211:06 amRNSSecond Price Monitoring Extn
26th Sep 202211:00 amRNSPrice Monitoring Extension
26th Sep 20227:00 amRNSInterim Results
8th Jul 20227:00 amRNSAdditional Loan Facilities and H1 Update
5th Jul 20228:54 amRNSHolding(s) in Company
22nd Jun 20222:30 pmRNSResult of AGM
20th Jun 20227:00 amRNSAppointment of Chrystal Capital Partners LLP
27th May 20227:00 amRNSNotice of AGM
26th May 20224:15 pmRNSHolding(s) in Company
26th May 20222:15 pmRNSHolding(s) in Company
24th May 20226:15 pmRNSHolding(s) in Company
20th May 20227:10 amRNSInvestor Presentation
18th May 20227:00 amRNSHolding(s) in Company
9th May 20227:00 amRNSFinal Results
5th May 20227:00 amRNSHolding(s) in Company
28th Apr 20228:38 amRNSHolding(s) in Company
19th Apr 20227:00 amRNSQ1 2022 and IO#9 Update
8th Apr 20221:07 pmRNSHolding(s) in Company
17th Mar 20227:00 amRNSDirector/PDMR Shareholding
16th Mar 20227:00 amRNSHolding(s) in Company
14th Mar 20227:00 amRNSDirector/PDMR Shareholding
11th Mar 20227:00 amRNSDirector/PDMR Shareholding
10th Mar 20227:00 amRNSDirector/PDMR Shareholding
9th Mar 20227:00 amRNSGrant of Share Options
8th Mar 20228:51 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.